Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma.
Niu Z, Shi Z, Wu G, Liu Y, Xie W, Liu F, Fan T, Shu K, Huang Q, Dai M, Zhi C, Qiu C, Li Y, Wu L, Liu F, Zhang Y, Wu T, Chen Y, Liu Z, Hao Y, Jiang Y.
Niu Z, et al.
Bioorg Chem. 2024 Dec 20;154:108080. doi: 10.1016/j.bioorg.2024.108080. Online ahead of print.
Bioorg Chem. 2024.
PMID: 39732089